Pancreatic Cancer Action Network Inc

Community engagement - nearly 55 volunteer affiliates with more than 2,645 volunteers leaders raise awareness of pancan and the disease and educate their communities about pancreatic cancer. Volunteers hosted nearly 55 purplestride events across the country this year, with 62,831 participants supporting survivors, families and friends, as well as providing educational information at the events. Purplestride participants raised more than $17 million in fiscal year 2025. We are also a founding member of the world pancreatic cancer coalition, composed of more than 100 pancreatic cancer patient advocacy groups from more than 30 countries and six continents. The coalition has an ongoing commitment to continuing education for its members and hosts world pancreatic cancer day every november to raise global awareness of the disease.

Patient services - provides free, personalized information and resources about pancreatic cancer, treatment options, clinical trials, diet and nutrition, specialists and support resources to help patients, caregivers and healthcare providers. We have the largest, most up-to-date clinical trials database in the country and provide constitutents with personalized searches so that they understand all of their treatment options. Our expert patient services case managers share more resources and speak with more pancreatic cancer patients than any other organization in the world. Last year alone, we had more than 38,000 interactions with patients with pancreatic cancer, their families, caregivers and healthcare proffessionals.

Government affairs and advocacy - we drive legislative support for increased federal research funding for pancreatic cancer. Our grassroots advocacy efforts led to the passage of the recalcitrant cancer research act, increased research dollars for pancreatic cancer at the national cancer institute, and led to a new pancreatic cancer research program at the department of defense. Since our founding, federal research funding for pancreatic cancer has increased by 1075 percent and continues to increase each year due to our efforts.